Jointown Pharmaceutical Group Co., Ltd

SHSE:600998 Rapporto sulle azioni

Cap. di mercato: CN¥26.2b

Jointown Pharmaceutical Group Crescita futura

Future criteri di controllo 1/6

Jointown Pharmaceutical Group prevede che gli utili e i ricavi cresceranno rispettivamente di 17.1% e 8% all'anno. Si prevede che l'EPS crescerà di 15% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 10.4% in 3 anni.

Informazioni chiave

17.1%

Tasso di crescita degli utili

15.0%

Tasso di crescita dell'EPS

Healthcare crescita degli utili23.1%
Tasso di crescita dei ricavi8.0%
Rendimento futuro del capitale proprio10.4%
Copertura analitica

Low

Ultimo aggiornamento08 Nov 2024

Aggiornamenti recenti sulla crescita futura

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Aug 29
Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Recent updates

We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Nov 17
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Aug 29
Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

Aug 26
Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Aug 01
These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jun 07
Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

May 21
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Apr 05
Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Previsioni di crescita degli utili e dei ricavi

SHSE:600998 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2026179,8703,082N/A4,2964
12/31/2025167,1702,721N/A2,2545
12/31/2024156,3732,353N/A4,5154
9/30/2024149,2052,0473171,291N/A
6/30/2024147,9532,039821,029N/A
3/31/2024148,5192,1513,1554,116N/A
12/31/2023150,1402,1743,6994,748N/A
9/30/2023151,8422,1705,2176,257N/A
6/30/2023151,7972,1595,4096,559N/A
3/31/2023147,3662,1942,3953,611N/A
12/31/2022140,4242,0852,7433,986N/A
9/30/2022133,2601,7823,6384,886N/A
6/30/2022128,4111,5451,3452,656N/A
3/31/2022124,9292,1411,8623,234N/A
12/31/2021122,4072,4482,0733,459N/A
9/30/2021122,6343,3392821,907N/A
6/30/2021121,4913,9883,1134,802N/A
3/31/2021116,3153,2582,0093,574N/A
12/31/2020110,8603,0751,9873,444N/A
9/30/2020106,4382,8492,9304,117N/A
6/30/2020102,4172,2422,0253,152N/A
3/31/2020102,0071,9762,3493,480N/A
12/31/201999,4971,7271,5762,768N/A
9/30/201996,7691,5881,4792,737N/A
6/30/201993,1161,5471,8823,123N/A
3/31/201989,5891,4465831,833N/A
12/31/201887,1361,341-5931,222N/A
9/30/201883,2301,262-1,949-231N/A
6/30/201880,1631,189N/A-2,213N/A
3/31/201877,3391,481N/A-2,221N/A
12/31/201773,9431,446N/A-1,012N/A
9/30/201770,7831,374N/A-2,586N/A
6/30/201767,9991,360N/A-198N/A
3/31/201764,925921N/A1,382N/A
12/31/201661,557877N/A431N/A
9/30/201658,367777N/A1,748N/A
6/30/201655,482754N/A193N/A
3/31/201653,091718N/A-783N/A
12/31/201549,589695N/A436N/A
9/30/201546,895640N/A-1,088N/A
6/30/201545,049602N/A-1,287N/A
3/31/201543,171566N/A-312N/A
12/31/201441,068561N/A-172N/A
9/30/201439,273533N/A-450N/A
6/30/201437,189509N/A-702N/A
3/31/201435,150493N/A-1,230N/A
12/31/201333,438478N/A138N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 600998 ( 17.1% all'anno) è superiore al tasso di risparmio ( 2.8% ).

Guadagni vs Mercato: Si prevede che gli utili di 600998 ( 17.1% all'anno) cresceranno più lentamente rispetto al mercato CN ( 26.1% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 600998 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 600998 ( 8% all'anno) crescerà più lentamente rispetto al mercato CN ( 13.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 600998 ( 8% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 600998 sarà basso tra 3 anni ( 10.4 %).


Scoprire le aziende in crescita